Guidelines for Diagnosis and Treatment of Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis): Esearch Committee on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis; Health Labour Sciences Research Grant for Research on Measures for intractable Diseases

Neurologia Medico-Chirurgica

Volumn 52, Issue 5, 2012, Pages 245-266

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; ANTIPYRETIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIULCER AGENT; ARGATROBAN; CLOPIDOGREL; GLYCEROL; HEPARIN; NORPHENAZONE; OZAGREL;

ARTERIAL OXYGEN SATURATION; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD PRESSURE REGULATION; BRAIN ANGIOGRAPHY; BRAIN CIRCULUS ARTERIOSUS; BRAIN EDEMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; BRAIN ISCHEMIA; BRAIN PROTECTION; BRAIN SURGERY; CEREBRAL REVASCULARIZATION; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONSERVATIVE TREATMENT; CONVULSION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG CHOICE; ELECTROENCEPHALOGRAM; FAMILIAL DISEASE; FEVER; GEOGRAPHIC DISTRIBUTION; HEMODYNAMICS; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; INTRACRANIAL HYPERTENSION; LIFESTYLE MODIFICATION; MAGNETIC RESONANCE ANGIOGRAPHY; MOLECULAR PATHOLOGY; MOYAMOYA DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; ONSET AGE; OUTCOME ASSESSMENT; OXYGEN THERAPY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE PERIOD; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; PREVALENCE; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; SEX RATIO; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STROKE; SURGICAL RISK; SYNDROME DELINEATION; TREATMENT INDICATION; ULCER;

EID: 84861586268     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.52.245     Document Type: Article

References (170)

1. Kudo T: [Occlusion of the internal carotid artery and the type of recovery of cerebral blood circulation]. Rin-sho Shinkeigaku 1: 199-200, 1960 (Japanese)
2. Kudo T: Spontaneous occlusion of the circle of Willis. A disease apparently confined to Japanese. Neurology 18: 485-496, 1968
3. Nishimoto A, Takeuchi S: Abnormal cerebrovascular network related to the internal carotid arteries. J Neu-rosurg 29: 255-260, 1968
4. Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease): [Research on Specified Diseases of the Ministry of Health, Labour and Welfare 1998 Research Report: Latest Diagnostic and Treatment Guidelines]. 1998 (Japanese)
5. Suzuki J, Kodama N: Cerebrovascular "Moyamoya" disease. 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology 2: 223-236, 1971
6. Suzuki J, Takaku A: Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20: 288-299, 1969
7. Suzuki J, Takaku A, Asahi M, Kowada M: [Examination of disease groups showing abnormal reticular vascular images at the base of the brain that frequently occur in Japanese people]. No To Shinkei 17: 767-776, 1965 (Japanese)
8. Takeuchi K, Shimizu K: [Hypogenesis of bilateral internal carotid arteries]. No To Shinkei 9: 37-43, 1957 (Japanese)
9. Baba T, Houkin K, Kuroda S: Novel epidemiological features of moyamoya disease. J Neurol Neurosurg Psychiatry 79: 900-904, 2008
10. Goto Y, Yonekawa Y: Worldwide distribution of moyamoya disease. Neurol Med Chir (Tokyo) 32: 883-886, 1992
11. Ikeda K, Iwasaki Y, Kashihara H, Hosozawa K, Anan K, Tamura M, Satoyoshi E, Ikeda H: Adult moyamoya disease in the asymptomatic Japanese population. J Clin Neurosci 13: 334-338, 2006
12. Ikezaki K, Han DH, Kawano T, Kinukawa N, Fukui M: A clinical comparison of definite moyamoya disease between South Korea and Japan. Stroke 28: 2513-2517, 1997
13. Kudo T: [The cause of spontaneous occlusion of the circle of Willis], in Tazaki Y (ed): [Adult Diseases Medical Examination Course, vol 3. Stroke]. Tokyo, Kane-hara, 1975, pp 253-259 (Japanese)
14. Mizukawa N, Ueda K, Takeuchi S, Nishimoto A: [Abnormal vascular network at the brain base: General theory: Statistical observation and problems]. Igaku No Ayumi 9: 279, 1974 (Japanese)
15. Ohki K, Hoshino H, Suzuki N, Nogawa S, Yamaguchi K: [2006 Database evaluation by the Research Committee on Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis)], in: [Research on Spontaneous Occlusion of the Circle of Willis of the Ministry of Health, Labour and Welfare (Group Leader: Hashimoto N) 2006 Study Report]. 2007, pp 19-25 (Japanese)
16. Wakai K, Tamakoshi A, Ikezaki K, Fukui M, Kawamura T, Aoki R, Kojima M, Lin Y, Ohno Y: Epidemiological features of moyamoya disease in Japan: findings from a nationwide survey. Clin Neurol Neurosurg 99 Suppl 2: S1-5, 1997
17. Yamaguchi K, Nogawa S, Fukuuchi Y: [National survey on spontaneous occlusion of the circle of Willis (moyamoya disease)]. Shinkei Naika 54: 319-327, 2001 (Japanese)
18. Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T: Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet 64: 533-537, 1999
19. Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M: Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol 15: 179-182, 2000
20. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK: Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis 22: 109-115, 2006
21. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y: Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36: 2148-2153, 2005
22. Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, Takenaka K, Ikeda H, Houkin K, Takagi Y, Kikuta K, Nozaki K, Hashimoto N, Koizumi A: Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology 70: 2357-2363, 2008
23. Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, Kikuta KI, Takagi Y, Nozaki K, Hashimoto N, Koizumi A: Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry 77: 1025-1029, 2006
24. Oka K, Yamashita M, Sadoshima S, Tanaka K: Cerebral haemorrhage in Moyamoya disease at autopsy. Virchows Arch A Pathol Anat Histol 392: 247-261, 1981
25. Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, Fukui M, Arinami T: A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet 49: 278-281, 2004
26. Takagi Y, Kikuta K, Sadamasa N, Nozaki K, Hashimoto N: Caspase-3-dependent apoptosis in middle cerebral arteries in patients with moyamoya disease. Neurosurgery 59: 894-901, 2006
27. Takahashi A, Sawamura Y, Houkin K, Kamiyama H, Abe H: The cerebrospinal fluid in patients with moyamoya disease (spontaneous occlusion of the circle of Willis) contains high level of basic fibroblast growth factor. Neurosci Lett 160: 214-216, 1993
28. Weber C, Tato F, Brandl T, Kellner W, Hoffmann U: Adult moyamoya disease with peripheral artery involvement. J Vasc Surg 34: 943-946, 2001
29. Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, Kuroda S, Abe H, Inoue T, Ikezaki K, Matsushima T, Fukui M: Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke 31: 930-935, 2000
30. Baba T, Kuroda S, Hokin K: [Recent trend of notified patients with moyamoya disease: Complete survey in Hokkaido 2002-2006], in: [Study on the Pathology and Treatment of Spontaneous Occlusion of the Circle of Willis (Chief Researcher: Hashimoto N) 2006 Comprehensive/Subdivided Study Report]. 2007, pp 4-5 (Japanese)
31. Fukuuchi Y (ed): [Research Committee on Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis): New database-importance of headache as a symptom], in: [Study on the Etiology and Pathology of Spontaneous Occlusion of the Circle of Willis (Chief Researcher: Yoshimoto T) 2002-2004 General Study Report]. 2005, pp 9-13 (Japanese)
32. Kudo T: Spontaneous occlusion of the circle of Willis. A disease apparently confined to Japanese. Neurology 18: 485-496, 1968
33. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y: Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicen-ter survey in Japan. Stroke 38: 1430-1435, 2007
34. Lyoo CH, Oh SH, Joo JY, Chung TS, Lee MS: Hemidystonia and hemichoreoathetosis as an initial manifestation of moyamoya disease. Arch Neurol 57: 1510-1512, 2000
35. Matsushima Y, Aoyagi M, Nariai T, Takada Y, Wakimoto H, Oki J, Srivatanakul K, Hirakawa K, Motoki K: [Long-term prognosis of intelligence in childhood moyamoya patients evaluated by Wechsler tests. I. Determination of standard changes in intelligence of non-operated patients]. Shoni No Noshinkei 21: 224-231, 1996 (Japanese)
36. Miyamoto S, Kikuchi H, Karasawa J, Nagata I, Ihara I, Yamagata S: Study of the posterior circulation in moyamoya disease. Part 2: Visual disturbances and surgical treatment. J Neurosurg 65: 454-460, 1986
37. Ohki K, Hoshino H, Suzuki N, Nogawa S, Yamaguchi K: [2006 Database evaluation by the Research Committee on Moyamoya Disease (Spontaneous Occlusion of the Circle of Willis)], in: [Research on Spontaneous Occlusion of the Circle of Willis of the Ministry of Health, Labour and Welfare (Group Leader: Hashimoto N)]. 2007, pp 19-25 (Japanese)
38. Yamaguchi K, Nogawa S, Fukuuchi Y: [National survey on spontaneous occlusion of the circle of Willis (moyamoya disease)]. Shinkei Naika 54: 319-327, 2001 (Japanese)
39. Aoki S, Hayashi N, Abe O, Shirouzu I, Ishigame K, Okubo T, Nakagawa K, Ohtomo K, Araki T: Radiation-induced arteritis: thickened wall with prominent enhancement on cranial MR images report of five cases and comparison with 18 cases of Moyamoya disease. Radiology 223: 683-688, 2002
40. Czartoski T, Hallam D, Lacy JM, Chun MR, Becker K: Postinfectious vasculopathy with evolution to moyamoya syndrome. J Neurol Neurosurg Psychiatry 76: 256-259, 2005
41. Horn P, Pfister S, Bueltmann E, Vajkoczy P, Schmie-dek P: Moyamoya-like vasculopathy (moyamoya syndrome) in children. Childs Nerv Syst 20: 382-391, 2004
42. Hosoda Y, Ikeda E, Hirose S: Histopathological studies on spontaneous occlusion of the circle of Willis (cerebrovascular moyamoya disease). Clin Neurol Neurosurg 99 Suppl 2: S203-208, 1997
43. Im SH, Oh CW, Kwon OK, Kim JE, Han DH: Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. J Neurosurg 102: 1013-1017, 2005
44. Inoue T, Matsushima T, Fujii K, Fukui M, Hasuo K, Matsuo H: [Akin moyamoya disease in children]. No Shinkei Geka 21: 59-65, 1993 (Japanese)
45. Ishikawa T, Houkin K, Yoshimoto T, Abe H: Vasoreconstructive surgery for radiation-induced vasculopathy in childhood. Surg Neurol 48: 620-626, 1997
46. Jea A, Smith ER, Robertson R, Scott RM: Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization. Pediatrics 116: e694-e701, 2005
47. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK: Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis 22: 109-115, 2006
48. Kestle JR, Hoffman HJ, Mock AR: Moyamoya phenomenon after radiation for optic glioma. J Neu-rosurg 79: 32-35, 1993
49. Rosser TL, Vezina G, Packer RJ: Cerebrovascular abnormalities in a population of children with neu-rofibromatosis type 1. Neurology 64: 553-555, 2005
50. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA: Long-term outcome in children with moyamoya syndrome after cranial revas-cularization by pial synangiosis. J Neurosurg 100: 142-149, 2004
51. Cultrera F, Giuffrida M, Alberio N, Chiaramonte I: Hemorrhagic unilateral moyamoya: report of one case. Neurologia 19: 277-279, 2004
52. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (moyamoya disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 Suppl 2: S238-240, 1997
53. Hirotsune N, Meguro T, Kawada S, Nakashima H, Ohmoto T: Long-term follow-up study of patients with unilateral moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2: S178-181, 1997
54. Honda N, Machida K, Takishima T, Kaizu H, Sugimoto E: Iodine-123 IMP SPECT before and after bypass surgery in a patient with occlusion of left anterior and middle cerebral arteries with basal abnormal telangiectasis (unilateral Moyamoya disease). Ann Nucl Med 1: 43-46, 1987
55. Houkin K, Abe H, Yoshimoto T, Takahashi A: Is "unilateral" moyamoya disease different from moyamoya disease? J Neurosurg 85: 772-776, 1996
56. Kasamo S, Asakura T, Yamamoto Y, Kobayashi E: Unilateral moyamoya disease associated with multiple aneurysms. A case report and review of the literature. Neurol Med Chir (Tokyo) 24: 30-34, 1984
57. Kawano T, Fukui M, Hashimoto N, Yonekawa Y: Follow-up study of patients with "unilateral" moyamoya disease. Neurol Med Chir (Tokyo) 34: 744-747, 1994
58. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK: Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis 22: 109-115, 2006
59. Kitagawa K: ["Guidelines for diagnosis of quasi-moyamoya disease" subdivided study report], in: [Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases 2006 Comprehensive/Subdivided Study Report]. 2007, p 68 (Japanese)
60. Kusaka N, Tamiya T, Adachi Y, Katayama S, Namba S, Tokunaga K, Sugiu K, Date I, Ohmoto T: Adult unilateral moyamoya disease with familial occurrence in two definite cases: a case report and review of the literature. Neurosurg Rev 29: 82-87, 2006
61. Matsushima T, Inoue T, Natori Y, Fujii K, Fukui M, Hasuo K, Kuwabara Y: Children with unilateral occlusion or stenosis of the ICA associated with surrounding moyamoya vessels-"unilateral" moyamoya disease. Acta Neurochir (Wien) 131: 196-202, 1994
62. Mineharu Y, Inoue K, Inoue S, Yamada S, Nozaki K, Hashimoto N, Koizumi A: Model-based linkage analyses confirm chromosome 19q13.3 as a susceptibility locus for intracranial aneurysm. Stroke 38: 1174-1178, 2007
63. Nagata I: ["Pathology and treatment of unilateral moyamoya disease" subdivided study report], in: [Health Labour Sciences Research Grant for Research on Measures for Intractable Diseases 2006 Comprehensive/Subdivided Study Report]. 2007, p 38 (Japanese)
64. Nagata S, Matsushima T, Morioka T, Matsukado K, Mihara F, Sasaki T, Fukui M: Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients. Neurosurgery 59: 830-837, 2006
65. Nijdam JR, Luijten JA, van Gijn J: Cerebral haemorrhage associated with unilateral Moyamoya syndrome. Clin Neurol Neurosurg 88: 49-51, 1986
66. Fujimura M, Mugikura S, Shimizu H, Tominaga T: [Diagnostic value of perfusion-weighted MRI for evaluating postoperative alteration of cerebral hemody-namics following STA-MCA anastomosis in patients with moyamoya disease]. No Shinkei Geka 34: 801- 809, 2006 (Japanese)
67. Fukui M: Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis (moyamoya disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan. Clin Neurol Neurosurg 99 Suppl 2: S238-240, 1997
68. Fushimi Y, Miki Y, Kikuta K, Okada T, Kanagaki M, Yamamoto A, Nozaki K, Hashimoto N, Hanakawa T, Fukuyama H, Togashi K: Comparison of 3.0- and 1.5-T three-dimensional time-of-flight MR angiography in moyamoya disease: preliminary experience. Radiology 239: 232-237, 2006
69. Houkin K, Aoki T, Takahashi A, Abe H: Diagnosis of moyamoya disease with magnetic resonance an-giography. Stroke 25: 2159-2164, 1994
70. Houkin K, Nakayama N, Kuroda S, Ishikawa T, Nona-ka T: How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography. Childs Nerv Syst 20: 734-741, 2004
71. Houkin K, Nakayama N, Kuroda S, Nonaka T, Shonai T, Yoshimoto T: Novel magnetic resonance an-giography stage grading for moyamoya disease. Cerebrovasc Dis 20: 347-354, 2005
72. Suzuki J, Kodama N: Cerebrovascular "Moyamoya" disease. 2. Collateral routes to forebrain via ethmoid sinus and superior nasal meatus. Angiology 22: 223-236, 1971
73. Suzuki J, Takaku A: Cerebrovascular "moyamoya" disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol 20: 288-299, 1969
74. Yamada I, Suzuki S, Matsushima Y: Moyamoya disease: comparison of assessment with MR angiography and MR imaging versus conventional angiography. Radiology 196: 211-218, 1995
75. Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T: Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67: 273-282, 2007
76. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M: Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 81: 843-850, 1994
77. Kodama N, Aoki Y, Hiraga H, Wada T, Suzuki J: Elec-troencephalographic findings in children with moyamoya disease. Arch Neurol 36: 16-19, 1979
78. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y: Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36: 2148-2153, 2005
79. Kuroda S, Kamiyama H, Isobe M, Houkin K, Abe H, Mitsumori K: Cerebral hemodynamics and "re-build-up" phenomenon on electroencephalogram in children with moyamoya disease. Childs Nerv Syst 11: 214-219, 1995
80. Kuwabara Y, Ichiya Y, Sasaki M, Yoshida T, Masuda K, Ikezaki K, Matsushima T, Fukui M: Cerebral hemodynamics and metabolism in moyamoya dis-ease-a positron emission tomography study. Clin Neurol Neurosurg 99 Suppl 2: S74-78, 1997
81. Miyamoto S: Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset-the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 44: 218-219, 2004
82. Morimoto M, Iwama T, Hashimoto N, Kojima A, Hayashida K: Efficacy of direct revascularization in adult Moyamoya disease: haemodynamic evaluation by positron emission tomography. Acta Neurochir (Wien) 141: 377-384, 1999
83. Nagata S, Matsushima T, Morioka T, Matsukado K, Mihara F, Sasaki T, Fukui M: Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients. Neurosurgery 59: 830-837, 2006
84. Piao R, Oku N, Kitagawa K, Imaizumi M, Matsushita K, Yoshikawa T, Takasawa M, Osaki Y, Kimura Y, Kajimoto K, Hori M, Hatazawa J: Cerebral hemodynamics and metabolism in adult moyamoya disease: comparison of angiographic collateral circulation. Ann Nucl Med 18: 115-121, 2004
85. Saito N, Nakagawara J, Nakamura H, Teramoto A: Assessment of cerebral hemodynamics in childhood moyamoya disease using a quantitative and a semiquantitative IMP-SPECT study. Ann Nucl Med 18: 323-331, 2004
86. So Y, Lee HY, Kim SK, Lee JS, Wang KC, Cho BK, Kang E, Lee DS: Prediction of the clinical outcome of pediatric moyamoya disease with postoperative basal/acetazolamide stress brain perfusion SPECT after revascularization surgery. Stroke 36: 1485-1489, 2005
87. Touho H, Karasawa J, Ohnishi H: Preoperative and postoperative evaluation of cerebral perfusion and vasodilatory capacity with 99mTc-HMPAO SPECT and acetazolamide in childhood Moyamoya disease. Stroke 27: 282-289, 1996
88. Choi JU, Kim DS, Kim EY, Lee KC: Natural history of moyamoya disease: comparison of activity of daily living in surgery and non surgery groups. Clin Neurol Neurosurg 99 Suppl 2: S11-18, 1997
89. Fujimura M, Kaneta T, Mugikura S, Shimizu H, Tominaga T: Temporary neurologic deterioration due to cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with adult-onset moyamoya disease. Surg Neurol 67: 273-282, 2007
90. Honda M, Kitagawa N, Tsutsumi K, Morikawa M, Nagata I, Kaminogo M: Magnetic resonance an-giography evaluation of external carotid artery tributaries in moyamoya disease. Surg Neurol 64: 325-330, 2005
91. Houkin K, Kuroda S, Nakayama N: Cerebral revas-cularization for moyamoya disease in children. Neu-rosurg Clin N Am 12: 575-584, ix, 2001
92. Houkin K, Nakayama N, Kuroda S, Ishikawa T, Nonaka T: How does angiogenesis develop in pediatric moyamoya disease after surgery? A prospective study with MR angiography. Childs Nerv Syst 20: 734-741, 2004
93. Ikezaki K, Matsushima T, Kuwabara Y, Suzuki SO, Nomura T, Fukui M: Cerebral circulation and oxygen metabolism in childhood moyamoya disease: a perioperative positron emission tomography study. J Neurosurg 81: 843-850, 1994
94. Ishikawa T, Houkin K, Kamiyama H, Abe H: Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke 28: 1170-1173, 1997
95. Iwama T, Hashimoto N, Yonekawa Y: The relevance of hemodynamic factors to perioperative ischemic complications in childhood moyamoya disease. Neu-rosurgery 38: 1120-1126, 1996
96. Kawaguchi T, Fujita S, Hosoda K, Shose Y, Hamano S, Iwakura M, Tamaki N: Multiple burr-hole operation for adult moyamoya disease. J Neurosurg 84: 468-476, 1996
97. Kuroda S, Houkin K, Kamiyama H, Abe H, Mit-sumori K: Regional cerebral hemodynamics in childhood moyamoya disease. Childs Nerv Syst 11: 584-590, 1995
98. Matsushima T, Inoue T, Suzuki SO, Fujii K, Fukui M, Hasuo K: Surgical treatment of moyamoya disease in pediatric patients-comparison between the results of indirect and direct revascularization procedures. Neurosurgery 31: 401-405, 1992
99. Matsushima Y, Aoyagi M, Nariai T, Takada Y, Wakimoto H, Ohki J, Akimoto H, Srivatanakul K, Hirakawa K: [Long-term prognosis of intelligence in childhood moyamoya patients evaluated by Wechsler tests: II. Childhood moyamoya patients who underwent encephalo-duro-arterio-synangiosis (EDAS) more than 10 years previously]. Shoni No Noshinkei 21: 232-238, 1996 (Japanese)
100. Miyamoto S, Nagata I, Karasawa J, Kikuchi H, Akiya-ma Y, Nozaki K, Hashimoto N: [Surgical treatment for moyamoya disease. Long-term prognosis after direct bypass in moyamoya disease]. No Socchu No Geka 28: 111-114, 2000 (Japanese)
101. Mizoi K, Kayama T, Yoshimoto T, Nagamine Y: Indirect revascularization for moyamoya disease: is there a beneficial effect for adult patients? Surg Neu-rol 45: 541-549, 1996
102. Morimoto M, Iwama T, Hashimoto N, Kojima A, Hayashida K: Efficacy of direct revascularization in adult Moyamoya disease: haemodynamic evaluation by positron emission tomography. Acta Neurochir (Wien) 141: 377-384, 1999
103. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA: Long-term outcome in children with moyamoya syndrome after cranial revas-cularization by pial synangiosis. J Neurosurg 100: 142-149, 2004
104. DeVeber G: In pursuit of evidence-based treatments for paediatric stroke: the UK and Chest guidelines. Lancet Neurol 4: 432-436, 2005
105. Kikuta K, Takagi Y, Nozaki K, Hanakawa T, Okada T, Mikuni N, Miki Y, Fushmi Y, Yamamoto A, Yamada K, Fukuyama H, Hashimoto N: Asymptomatic microbleeds in moyamoya disease: T2*-weighted gradient-echo magnetic resonance imaging study. J Neurosurg 102: 470-475, 2005
106. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y: Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of multicen-ter survey in Japan. Stroke 38: 1430-1435, 2007
107. Members of Subcommittee for Guidelines for Intravenous tPA (Alteplase) Therapy, Committee for Medical Improvement and Social Insurance Japan Stroke Society (Subcommittee Leader: Yamaguchi T): [Guidelines for proper treatment with intravenous tPA (alteplase) therapy. Oct. 2005]. Nosotchu 27: 327-354, 2005 (Japanese)
108. Shinohara Y, Yoshimoto T, Fukuuchi Y, Ishigami S (eds); Committee for Japanese Guidelines for the Management of Stroke: [Japanese Guidelines for the Management of Stroke 2004] Tokyo, Kyowa Kikaku, 2004 (Japanese)
109. Soman T, Rafay MF, Hune S, Allen A, MacGregor D, deVeber G: The risks and safety of clopidogrel in pediatric arterial ischemic stroke. Stroke 37: 1120-1122, 2006
110. Toriyama T, Kageyama M, Kimura F, Yamada T, Ishibashi A: [Post-marketing surveillance on edara-vone (Radicut Inj. 30 mg) for cerebral infarction in children]. Shonika Rinsho 61: 155-164, 2008 (Japanese)
111. Aoki N: Cerebrovascular bypass surgery for the treatment of Moyamoya disease: unsatisfactory outcome in the patients presenting with intracranial hemorrhage. Surg Neurol 40: 372-377, 1993
112. Fujii K, Ikezaki K, Irikura K, Miyasaka Y, Fukui M: The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neu-rosurg 99 Suppl 2: S194-195, 1997
113. Han DH, Kwon OK, Byun BJ, Choi BY, Choi CW, Choi JU, Choi SG, Doh JO, Han JW, Jung S, Kang SD, Kim DJ, Kim HI, Kim HD, Kim MC, Kim SC, Kim SC, Kim Y, Kwun BD, Lee BG, Lim YJ, Moon JG, Park HS, Shin MS, Song JH, Suk JS, Yim MB; Korean Society for Cerebrovascular Disease: A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 142: 1263-1274, 2000
114. Houkin K, Kamiyama H, Abe H, Takahashi A, Kuro-da S: Surgical therapy for adult moyamoya disease. Can surgical revascularization prevent the recurrence of intracerebral hemorrhage? Stroke 27: 1342-1346, 1996
115. Karasawa J, Hosoi K, Morisako T: [Revascularization for hemorrhagic Moyamoya disease], in: [Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health, Labour and Welfare Annual Report 2000]. 2001, pp 55-58 (Japanese)
116. Kawaguchi S, Okuno S, Sakaki T: Effect of direct arterial bypass on the prevention of future stroke in patients with the hemorrhagic variety of moyamoya disease. J Neurosurg 93: 397-401, 2000
117. Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A: Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 93: 976-980, 2000
118. Kuroda S, Houkin K, Kamiyama H, Abe H: Effects of surgical revascularization on peripheral artery aneurysms in moyamoya disease: report of three cases. Neurosurgery 49: 463-468, 2001
119. Miyamoto S: Study design for a prospective randomized trial of extracranial-intracranial bypass surgery for adults with moyamoya disease and hemorrhagic onset-the Japan Adult Moyamoya Trial Group. Neurol Med Chir (Tokyo) 44: 218-219, 2004
120. Miyamoto S, Akiyama Y, Nagata I, Karasawa J, Nozaki K, Hashimoto N, Kikuchi H: Long-term outcome after STA-MCA anastomosis for moyamoya disease. Neurosurg Focus 5(5): e5, 1998
121. Nakagawa I, Kawaguchi S, Iida J, Sakaki T: [Direct bypass of STA-MCA anastomosis prevents future stroke in patients with the hemorrhagic type of moyamoya disease]. No Socchu No Geka 32: 416-420, 2004 (Japanese)
122. Suzuki S, Maeyama R, Nagatomi H, Kuromatsu C, Ito M, Matsunaga M, Matsuno H, Matsubara T, Kamikaseda K: [Surgical treatment for adult patients with moyamoya disease. With special reference to hemorrhagic type]. No Socchu No Geka 20: 463-467, 1992 (Japanese)
123. Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y: Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-up study. Stroke 30: 2272-2276, 1999
124. Chiu D, Shedden P, Bratina P, Grotta JC: Clinical features of moyamoya disease in the United States. Stroke 29: 1347-1351, 1998
125. Ezura M, Yoshimoto T, Fujiwara S, Takahashi A: [Long-term follow-up of moyamoya disease (5 to 27 years)]. Shoni No Noshinkei 18: 461-465, 1993 (Japanese)
126. Ezura M, Yoshimoto T, Fujiwara S, Takahashi A, Shi-rane R, Mizoi K: Clinical and angiographic follow-up of childhood-onset moyamoya disease. Childs Nerv Syst 11: 591-594, 1995
127. Fujii K, Ikezaki K, Irikura K, Miyasaka Y, Fukui M: The efficacy of bypass surgery for the patients with hemorrhagic moyamoya disease. Clin Neurol Neu-rosurg 99 Suppl 2: S194-195, 1997
128. Golby AJ, Marks MP, Thompson RC, Steinberg GK: Direct and combined revascularization in pediatric moyamoya disease. Neurosurgery 45: 50-60, 1999
129. Hallemeier CL, Rich KM, Grubb RL Jr, Chicoine MR, Moran CJ, Cross DT 3rd, Zipfel GJ, Dacey RG Jr, Der-deyn CP: Clinical features and outcome in North American adults with moyamoya phenomenon. Stroke 37: 1490-1496, 2006
130. Han DH, Kwon OK, Byun BJ, Choi BY, Choi CW, Choi JU, Choi SG, Doh JO, Han JW, Jung S, Kang SD, Kim DJ, Kim HI, Kim HD, Kim MC, Kim SC, Kim SC, Kim Y, Kwun BD, Lee BG, Lim YJ, Moon JG, Park HS, Shin MS, Song JH, Suk JS, Yim MB; Korean Society for Cerebrovascular Disease: A co-operative study: clinical characteristics of 334 Korean patients with moyamoya disease treated at neurosurgical institutes (1976-1994). The Korean Society for Cerebrovascular Disease. Acta Neurochir (Wien) 142: 1263-1274, 2000
131. Houkin K, Abe H, Yoshimoto T, Takahashi A: Is "unilateral" moyamoya disease different from moyamoya disease? J Neurosurg 85: 772-776, 1996
132. Houkin K, Ishikawa T, Yoshimoto T, Abe H: Direct and indirect revascularization for moyamoya disease surgical techniques and peri-operative complications. Clin Neurol Neurosurg 99 Suppl 2: S142-145, 1997
133. Ikezaki K, Inamura T, Kawano T, Fukui M: Clinical features of probable moyamoya disease in Japan. Clin Neurol Neurosurg 99 Suppl 2: S173-177, 1997
134. Imaizumi C, Imaizumi T, Osawa M, Fukuyama Y, Takeshita M: Serial intelligence test scores in pediatric moyamoya disease. Neuropediatrics 30: 294-299, 1999
135. Imaizumi T, Hayashi K, Saito K, Osawa M, Fukuya-ma Y: Long-term outcomes of pediatric moyamoya disease monitored to adulthood. Pediatr Neurol 18: 321-325, 1998
136. Irikura K, Miyasaka Y, Kurata A, Tanaka R, Fujii K, Yada K, Kan S: A source of haemorrhage in adult patients with moyamoya disease: the significance of tributaries from the choroidal artery. Acta Neurochir (Wien) 138: 1282-1286, 1996
137. Ishikawa T, Houkin K, Kamiyama H, Abe H: Effects of surgical revascularization on outcome of patients with pediatric moyamoya disease. Stroke 28: 1170-1173, 1997
138. Iwama T, Morimoto M, Hashimoto N, Goto Y, Toda-ka T, Sawada M: Mechanism of intracranial rebleed-ing in moyamoya disease. Clin Neurol Neurosurg 99 Suppl 2: S187-190, 1997
139. Karasawa J, Touho H, Ohnishi H, Miyamoto S, Kikuchi H: Long-term follow-up study after ex-tracranial-intracranial bypass surgery for anterior circulation ischemia in childhood moyamoya disease. J Neurosurg 77: 84-89, 1992
140. Kawano T, Fukui M, Hashimoto N, Yonekawa Y: Follow-up study of patients with "unilateral" moyamoya disease. Neurol Med Chir (Tokyo) 34: 744-747, 1994
141. Kelly ME, Bell-Stephens TE, Marks MP, Do HM, Steinberg GK: Progression of unilateral moyamoya disease: A clinical series. Cerebrovasc Dis 22: 109-115, 2006
142. Kim DS, Yoo DS, Huh PW, Kang SG, Cho KS, Kim MC: Combined direct anastomosis and en-cephaloduroarteriogaleosynangiosis using inverted superficial temporal artery-galeal flap and superficial temporal artery-galeal pedicle in adult moyamoya disease. Surg Neurol 66: 389-395, 2006
143. Kim SK, Seol HJ, Cho BK, Hwang YS, Lee DS, Wang KC: Moyamoya disease among young patients: its aggressive clinical course and the role of active surgical treatment. Neurosurgery 54: 840-846, 2004
144. Kobayashi E, Saeki N, Oishi H, Hirai S, Yamaura A: Long-term natural history of hemorrhagic moyamoya disease in 42 patients. J Neurosurg 93: 976-980, 2000
145. Kohno K, Nagato S, Oka Y, Ohue S, Nakagawa K, Ohta S, Kumon Y, Sakaki S: [Evaluation of long-term prognosis and cerebral blood flow in adult patients with moyamoya disease with and without vascular reconstructive surgery]. No Shinkei Geka Journal 6: 456-463, 1997 (Japanese)
146. Kohno K, Oka Y, Kohno S, Ohta S, Kumon Y, Sakaki S: Cerebral blood flow measurement as an indicator for an indirect revascularization procedure for adult patients with moyamoya disease. Neurosurgery 42: 752-758, 1998
147. Komiyama M, Yasui T, Kitano S, Sakamoto H, Fujita-ni K, Matsuo S: Moyamoya disease and pregnancy: case report and review of the literature. Neurosurgery 43: 360-369, 1998
148. Kuroda S, Hashimoto N, Yoshimoto T, Iwasaki Y: Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: results of mul-ticenter survey in Japan. Stroke 38: 1430-1435, 2007
149. Kuroda S, Houkin K, Ishikawa T, Nakayama N, Nan-ba R, Kamiyama H, Nakagawa Y, Iwasaki Y, Abe H: [Overall outcome after surgical revascularization in childhood and adult moyamoya disease]. No Socchu No Geka 30: 369-374, 2002 (Japanese)
150. Kuroda S, Houkin K, Ishikawa T, Takahashi A, Kamiyama H, Nakagawa Y, Abe H: [Long-term outcome after surgical revascularization in childhood moyamoya disease]. No Socchu No Geka 28: 421-426, 2000 (Japanese)
151. Kuroda S, Houkin K, Kamiyama H, Abe H: Effects of surgical revascularization on peripheral artery aneurysms in moyamoya disease: report of three cases. Neurosurgery 49: 463-468, 2001
152. Kuroda S, Ishikawa T, Houkin K, Nanba R, Hokari M, Iwasaki Y: Incidence and clinical features of disease progression in adult moyamoya disease. Stroke 36: 2148-2153, 2005
153. Kuroda S, Nanba R, Ishikawa T, Houkin K, Kamiya-ma H, Iwasaki Y: [Clinical manifestations of infantile moyamoya disease]. No Shinkei Geka 31: 1073-1078, 2003 (Japanese)
154. Kurokawa T, Tomita S, Ueda K, Narazaki O, Hanai T, Hasuo K, Matsushima T, Kitamura K: Prognosis of occlusive disease of the circle of Willis (moyamoya disease) in children. Pediatr Neurol 1: 274-277, 1985
155. Matsushima Y, Aoyagi M, Nariai T, Nojiri T, Ohno K: [Headache in pediatric moyamoya patients: pre-and postoperative changes]. Shoni No Noshinkei 25: 442-447, 2000 (Japanese)
156. Matsushima Y, Aoyagi M, Nariai T, Takada Y, Hirakawa K: Long-term intelligence outcome of post-encephalo-duro-arterio-synangiosis childhood moyamoya patients. Clin Neurol Neurosurg 99 Suppl 2: S147-150, 1997
157. Miyamoto S, Akiyama Y, Nagata I, Karasawa J, Nozaki K, Hashimoto N, Kikuchi H: Long-term outcome after STA-MCA anastomosis for moyamoya disease. Neurosurg Focus 5(5): e5, 1998
158. Miyamoto S, Nagata I, Karasawa J, Kikuchi H, Akiyama Y, Nozaki K, Hashimoto N: [Long-term prognosis after direct bypass in moyamoya disease Surgical treatment for moyamoya disease)]. No Soc-chu No Geka 28: 111-114, 2000 (Japanese)
159. Morioka M, Hamada J, Todaka T, Yano S, Kai Y, Ushio Y: High-risk age for rebleeding in patients with hemorrhagic moyamoya disease: long-term follow-up study. Neurosurgery 52: 1049-1055, 2003
160. Nagata S, Matsushima T, Morioka T, Matsukado K, Mihara F, Sasaki T, Fukui M: Unilaterally symptomatic moyamoya disease in children: long-term follow-up of 20 patients. Neurosurgery 59: 830-837, 2006
161. Nanba R, Kuroda S, Takeda M, Shichinohe H, Nakayama N, Ishikawa T, Houkin K, Iwasaki Y: [Clinical features and outcomes of 10 asymptomatic adult patients with moyamoya disease]. No Shinkei Geka 31: 1291-1295, 2003 (Japanese)
162. Okada Y, Shima T, Nishida M, Yamane K, Yamada T, Yamanaka C: Effectiveness of superficial temporal artery-middle cerebral artery anastomosis in adult moyamoya disease: cerebral hemodynamics and clinical course in ischemic and hemorrhagic varieties. Stroke 29: 625-630, 1998
163. Sainte-Rose C, Oliveira R, Puget S, Beni-Adani L, Boddaert N, Thorne J, Wray A, Zerah M, Bourgeois M: Multiple bur hole surgery for the treatment of moyamoya disease in children. J Neurosurg 105: 437-443, 2006
164. Scott RM, Smith JL, Robertson RL, Madsen JR, Soriano SG, Rockoff MA: Long-term outcome in children with moyamoya syndrome after cranial revas-cularization by pial synangiosis. J Neurosurg 100: 142-149, 2004
165. Seol HJ, Wang KC, Kim SK, Hwang YS, Kim KJ, Cho BK: Headache in pediatric moyamoya disease: review of 204 consecutive cases. J Neurosurg 103: 439-442, 2005
166. Suzuki S, Maeyama R, Nagatomi H, Kuromatsu C, Ito M, Matsunaga M, Matsuno H, Matsubara T, Kamikaseda K: [Surgical treatment for adult patients with moyamoya disease. With special reference to hemorrhagic type]. No Socchu No Geka 20: 463-467, 1992 (Japanese)
167. Takahashi J, Ikeda T, Iihara K, Miyamaoto S: [A nationwide survey on pregnancy and delivery management in association with moyamoya disease ( Management of pregnancy and delivery in neurosurgical patients)]. No Shinkei Geka Journal 18: 367-375, 2009 (Japanese)
168. Wanifuchi H, Takeshita M, Izawa M, Aoki N, Kaga-wa M: Management of adult moyamoya disease. Neu-rol Med Chir (Tokyo) 33: 300-305, 1993
169. Yamada M, Fujii K, Fukui M: [Clinical features and outcomes in patients with asymptomatic moyamoya disease-from the results of nation-wide questionnaire survey]. No Shinkei Geka 33: 337-342, 2005 (Japanese)
170. Yoshida Y, Yoshimoto T, Shirane R, Sakurai Y: Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage: An extensive follow-up study. Stroke 30: 2272-2276, 1999